×

About Us
Technologies
Programs
- Oncology
- Diabetes
Clinical Trials
Investors
News
Contact

MENU

Events

Stay tuned for replay links from recent industry and investor presentations.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

About Us
Clinical Trials
Investors
Downloads
Press Releases

X
Facebook
LinkedIn

Latest News

Genprex – Developing Novel Gene Therapies in Cancer with Tumor Suppressor Genes and Diabetes Converting Alpha Cells into Beta Cells to Produce Insulin Sep 23
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes Sep 23
Genprex Announces Formation of Mesothelioma Clinical Advisory Board Sep 19
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Sep 9

Designed and Secured by Barsec

Copyright ©2024 all rights reserved.
Home - Privacy Policy - Terms of Use